Ionis Pharmaceuticals, Inc. (IONS) /
The debt of Ionis Pharmaceuticals, Inc. over the past 10 years
Chart Ionis Pharmaceuticals, Inc.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, Ionis Pharmaceuticals, Inc. had liquid cash of $2.68B and total debt of $1.75B: net cash of $926.16M. It had more liquid cash than debt at all 10 year-ends shown. Total debt was highest at the end of fiscal 2025 ($1.75B) and lowest at the end of fiscal 2016 ($500.51M).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $2.68B* | $1.75B | $926.16M |
| 2024ended Dec 31, 2024 | $2.3B* | $1.19B | $1.1B |
| 2023ended Dec 31, 2023 | $2.33B* | $1.23B | $1.1B |
| 2022ended Dec 31, 2022 | $1.99B* | $1.17B | $820.12M |
| 2021ended Dec 31, 2021 | $2.11B* | $1.16B | $953.54M |
| 2020ended Dec 31, 2020 | $1.89B* | $879.65M | $1.01B |
| 2019ended Dec 31, 2019 | $2.5B* | $710.04M | $1.79B |
| 2018ended Dec 31, 2018 | $2.08B* | $581.95M | $1.5B |
| 2017ended Dec 31, 2017 | $1.02B* | $533.11M | $489.6M |
| 2016ended Dec 31, 2016 | $665.22M* | $500.51M | $164.71M |
Fiscal years as Ionis Pharmaceuticals, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Ionis Pharmaceuticals, Inc.
- The revenue of Ionis Pharmaceuticals, Inc.
- The profitability of Ionis Pharmaceuticals, Inc.
- The cash flow of Ionis Pharmaceuticals, Inc.
- All of Ionis Pharmaceuticals, Inc.'s financials, charted
Companies of a similar size
- EPAMEPAM SYSTEMS, INC.
- CVLTCommvault Systems, Inc
- CAGCONAGRA BRANDS, INC.
- MSAMSA SAFETY INC
- KEXKIRBY CORPORATION
Not investment advice. This page shows what Ionis Pharmaceuticals, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.